Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated:  7/5/2016
Digestive Disease Care, PC
mi
from
New Hyde Park, NY
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated: 7/5/2016
Digestive Disease Care, PC
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated:  7/5/2016
Great Lakes Medical Research, LLC
mi
from
Willoughby, OH
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated: 7/5/2016
Great Lakes Medical Research, LLC
mi
from
Willoughby, OH
Click here to add this to my saved trials
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated:  7/5/2016
Innovative Clinical Research
mi
from
Rapd City, SD
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated: 7/5/2016
Innovative Clinical Research
mi
from
Rapd City, SD
Click here to add this to my saved trials
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated:  7/5/2016
Digestive Disease Center of South Texas, P.L.L.C
mi
from
San Antonio, TX
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated: 7/5/2016
Digestive Disease Center of South Texas, P.L.L.C
mi
from
San Antonio, TX
Click here to add this to my saved trials
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated:  7/5/2016
Barzilai Medical Center
mi
from
Ashkelon,
Exalenz Dual Mode System Compared to Biopsy for H.Pylori Detection
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Biopsy Results
Status: Enrolling
Updated: 7/5/2016
Barzilai Medical Center
mi
from
Ashkelon,
Click here to add this to my saved trials
Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
The Effect of Moderate Hepatic Impairment on the Pharmacokinetics Following Single-Dose Inhaled Administration of TD-4208
Status: Enrolling
Updated:  7/11/2016
Orlando Clinical Research Center (OCRD)
mi
from
Orlando, FL
Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
The Effect of Moderate Hepatic Impairment on the Pharmacokinetics Following Single-Dose Inhaled Administration of TD-4208
Status: Enrolling
Updated: 7/11/2016
Orlando Clinical Research Center (OCRD)
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Sun City, AZ
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Sun City, AZ
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Mission Hills, CA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Littleton, CO
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Miramar, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Winter Park, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Savannah, GA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Oak Lawn, IL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Hammond, LA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Hammond, LA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Rochester Hills, MI
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Ocean Springs, MS
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Mexico, MO
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Great Neck, NY
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Rochester, NY
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Winston Salem, NC
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Phoenixville, PA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Phoenixville, PA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Pasadena, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Pasadena, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Sugar Land, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Seattle, WA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Wauwatosa, WI
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
mi
from
Innsbruck,
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
mi
from
Innsbruck,
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Mission Hills, CA
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Miramar, FL
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Mexico, MO
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Winter Park, FL
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Single-dose Linaclotide for Capsule Endoscopy Preparation
Single-dose Linaclotide for Capsule Endoscopy Preparation
Status: Enrolling
Updated:  7/13/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Single-dose Linaclotide for Capsule Endoscopy Preparation
Single-dose Linaclotide for Capsule Endoscopy Preparation
Status: Enrolling
Updated: 7/13/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Wichita
mi
from
Wichita, KA
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Duluth
mi
from
Duluth, MN
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated:  7/13/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
Status: Enrolling
Updated: 7/13/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials